Mental Health Really Matters: Lung Cancer Diagnosis Has the Greatest Risk of Suicide among Cancer Patients in USA – SEER Database Analysis
By Mohamed Rahouma, MD, Mohamed Kamel, MD, and Jeffrey L. Port, MD A cancer diagnosis can be overwhelming, especially if someone has limited social support. Previous international reports have indicated […] Read more
Posted: June 2017 Despite very encouraging progress in the development and use of immunotherapy for patients with non-small cell lung cancer, much confusion remains regarding patient selection for each therapy. […] Read more
Posted: June 2017 For the past 40 years the International Association for the Study of Lung Cancer has remained the only society exclusively dedicated to the study and treatment of […] Read more
Posted: April 2017 By Giorgio Vittorio Scagliotti, MD, PhD The ambition to personalize medicine is intrinsic to the mission of every individual physician with the twin goals of reducing drug-related […] Read more
Posted: February 2017 By Cynthia L. Kryder, MS Clinical trials are essential to the development of new, potentially lifesaving therapies for patients with cancer. Well-designed clinical trials contribute to medical […] Read more
Posted: February 2017 By Caicun Zhou, MD As part of an ongoing series, IASLC Lung Cancer News is exploring how drug approval processes differ country by country, and continent by […] Read more
Posted: February 2017 Q&A with with Ronan J. Kelly, MB BCh, MBA Q: What is the impetus for the development of clinical pathways? A: The incidence of cancer in the US […] Read more
Posted: February 2017 By Lori Alexander, MTPW, ELS, MWC Drug development has become a biomarker- driven process, necessitating new approaches and clinical trial designs. Speakers addressed these issues in the […] Read more
By Sanjay Popat, FRCP, PhD United Kingdom Healthcare System The United Kingdom (UK) has a unique healthcare system: the National Health Service (NHS), a publicly funded, singlepayer system. Founded by […] Read more
By Matteo Giaj Levra, MD, and Silvia Novello MD, PhD In September, the 2016 ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up of metastatic nonsmall cell lung cancer (NSCLC) […] Read more